Hepatitis C: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• AKT 0
• IL-17 0
• PD-L1 0
• PNPLA3 0
• PPAR 0
• TP53 0
• VEGF 0
• HMGB1 0
• IL-6 0
• mTOR 0
• PI3K 0
• YAP 0
• ATM 0
• BCL-2 0
• CD19 0
• CD40 0
• CTLA-4 0
• CTNNB1 0
• DPP-4 0
• ERK 0
• FAK 0
• GPC3 0
• HDAC 0
• HIF-1 0
• HSP90 0
• IDH 0
• IL-1 0
• IL-23 0
• NLRP3 0
• NRAS 0
• PCSK9 0
• PD-1 0
• PTEN 0
• SGLT2 0
• STAT3 0
• TNF 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIDA · R01

  Closing Gaps in the Hepatitis C Cascade of Care: Creating Data-Driven Solutions Using EHRs and Registries

  University of California, San Francisco· San Francisco, Egyesült Államok· 722 155 USD awarded in fiscal year 2026· until 2031. júl.

• NIH NIDA · R34

  SMART: strengthening motivation and adherence to HIV prevention and treatment among people who use drugs in Atlanta

  Florida State University· Tallahassee, Egyesült Államok· 233 666 USD awarded in fiscal year 2026· until 2029. aug.

• NIH NIDA · R01

  Incorporating real-world patient and clinician preferences in simulating Integrated Models of Prenatal care for Addiction and Hepatitis C Treatment (IMPACT)

  Boston Medical Center· Boston, Egyesült Államok· 847 117 USD awarded in fiscal year 2026· until 2031. jún.

• NIH NIAID · U19

  Rational hepatitis C virus vaccine design informed by mechanisms of spontaneous clearance or persistence of infection

  Johns Hopkins University· Baltimore, Egyesült Államok· 2 849 722 USD awarded in fiscal year 2026· until 2031. júl.

• NIH NIDDK · R01

  Stakeholder Engagement and Modeling for Adoption of a Novel Cirrhosis Detection Algorithm

  University of Michigan at Ann Arbor· Ann Arbor, Egyesült Államok· 810 994 USD awarded in fiscal year 2026· until 2030. jún.

• European Commission (Horizon Europe) · HORIZON-ERC

  Single-molecule Nanopore Analysis Platform for RNA Readout (SNAPRR)

  The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin· Dublin, Írország· EU contribution 1 670 246 EUR· until 2031. okt.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-JU-RIA

  Ravidasvir to combat the emergence and spread of artemisinin resistance in Africa: a phase 2 and 3 clinical trial to assess its efficacy (RAMP)

  Institut National de la Sante Et de la Recherche Medicale· Paris, Franciaország· EU contribution 10 298 969 EUR· until 2031. aug.· 6 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Non-canonical modification of viral RNA (MOVIRNA)

  Kobenhavns Universitet· Kobenhavn, Dánia· EU contribution 1 996 986 EUR· until 2029. jún.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-RIA

  Cancer Prevention at Work (CPW): Occupational health surveillance in the implementation of prevention of infection-related cancer.

  Alma Mater Studiorum - Universita di Bologna· Bologna, Olaszország· EU contribution 5 801 578 EUR· until 2027. ápr.· 7 countries

• European Commission (Horizon 2020) · ERC-ADG

  Targeted strategies for prevention and treatment of fibrosis-associated liver cancer (FIBCAN)

  Institut National de la Sante Et de la Recherche Medicale· Paris, Franciaország· EU contribution 2 430 000 EUR· until 2028. jún.· 2 countries

10 of 320 running projects, newest first. Listed amounts together: 235,6 M USD + 22,2 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 3
• Mendelian Randomization Analysis 5
• CRISPR-Cas Systems 9
• Gene Expression Profiling 12
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 4
• Proteomics 5
• Metabolomics 3
• Mass Spectrometry 1
• Flow Cytometry 5
• Immunohistochemistry 8
• Positron-Emission Tomography 2
• Magnetic Resonance Imaging 7
• Machine Learning 22
• Deep Learning 2
• Cohort Studies 84
• Genome-Wide Association Study 5

• Integrating HCV Testing and Treatment Into HIV Care: A Cohort Study of the HCV Care Cascade in Southwest China.

  Liver Int, 2026. nov.

• Social and clinical determinants of liver transplant evaluation in hepatocellular carcinoma: A multicenter cohort study.

  Hepatol Commun, 2026. okt.

• Optimizing the HCV Care Continuum in Primary Care: Opportunistic Screening With Point-Of-Care RNA Testing and Immediate Linkage-To-Care in Rio de Janeiro, Brazil.

  J Viral Hepat, 2026. okt.

• Linking Military Blast Exposure to Veterans Health Administration Diagnoses: Chronic Health Outcomes in the Millennium Cohort Study.

  Neurology, 2026. szept.

• An Exploratory Intersectional Analysis of Lifetime Syphilis Prevalence Among People Who Inject Drugs in Montreal, Canada.

  Sex Transm Dis, 2026. szept.

• Pre-ART Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio and the Risk of Non-AIDS-events, AIDS-Events, and Mortality in People With HIV.

  J Acquir Immune Defic Syndr, 2026. szept.

• Developing a Preterm Birth Prediction Model in Pregnant People With HIV Using a Population-Based Cohort.

  J Acquir Immune Defic Syndr, 2026. szept.

• Viral seropositivity in a Brazilian cohort of patients with multiple sclerosis: A retrospective descriptive study.

  J Neurol Sci, 2026. aug.

• Persisting disparities in hepatitis B diagnoses, associated risk factors, and time to diagnosis among migrants compared with Danish-born populations: a matched cohort study.

  Eur J Public Health, 2026. aug.

• Screening for Advanced Liver Fibrosis: Comparing Serum Indices With Elastography in a Nationally Representative U.S. Cohort.

  Mil Med, 2026. aug.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.